4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0000899243-22-007525
Options or other derivatives
- Chief Business Officer acquired 190,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Yonehiro Grant · Chief Business Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-18 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +190,000 | 190,000 | D |
Loading xslF345X03/doc4.xml…